Lv1
60 积分 2024-06-18 加入
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
11天前
已完结
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
23天前
已完结
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-Type Non-Small Cell Lung Cancer
1个月前
已完结
Data from SEMA3G–NRP1 Signaling Functions as an Immune Checkpoint That Enables Tumor Immune Evasion by Impairing T-cell Cytotoxicity
1个月前
已完结
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance
1个月前
已完结
Upregulation of Trop-2 quantitatively stimulates human cancer growth
1个月前
已完结
The CD8α–PILRα interaction maintains CD8 + T cell quiescence
1个月前
已完结
PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity
1个月前
已完结
Novel drug targets in 2024
1个月前
已完结
Novel immune checkpoint targets: A promising therapy for cancer treatments
1个月前
已完结
皖公网安备34019202002308
